Abstract
The chronic phase of Chagas disease is presented in three clinical forms: indeterminate (no clinical manifestations), cardiac disease, and megaviscera syndromes. The latter comprise up to 18% of the infected individuals and most often present a compromise of the esophagus and colon. The physiological function of these organs depends on a perfect coordination/synchronization of muscular constriction and relaxation waves, in order to push a rather hard material (alimentary bolus and feces) through their cavity, and a coordinated transposition of two sphincters. When this function is hampered, a progressive increase in the diameter of both organs is produced, termed megaesophagus and megacolon. A clue for the cause of this dysfunction is the selective destruction of parasympathetic plexus neurons by the etiological agent of the disease, Trypanosoma cruzi. Besides motor alterations, secretory and absorptive functions may be affected. Why these features are observed in only some of the infected is not clear. A markedly discrete geographical distribution of digestive Chagas disease cases below the equatorial line suggests it may be due to the type of circulating T. cruzi lineages (TcII and TcV). Different incidences according to gender and age are also seen. A number of neurotransmitters and neuropeptides have been linked to Chagas disease-associated megaviscera syndromes. Dysphagia and obstipation are clinical hallmarks of this disease, but serological diagnosis is necessary to exclude other possible causes, like idiopathic megaviscera. Association with cardiac involvement is observed in 20–30% of the cases, and 40% of the cases exhibit both megaesophagus and megacolon. Progression from mild to severe disease is seen in some of the cases, in which surgery is ultimately required. Fecaloma and volvulus are common complications of megacolon. In recent years, new methods have significantly improved post-surgery prognosis. Alternative treatments with botulinum toxin and by mechanical dilatation are indicated for specific cases. Other hollow viscera may be involved, albeit at lower frequencies, such as the stomach, duodenum, gallbladder, ureter, bladder, and others. However, these are usually also associated with megacolon and/or megaesophagus.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Koberle F. Patologische befunde an den muskularen hoholorganen bei der experimentellen Chagaskrankheit. Zentralkbl Allg Path Path Anat. 1956;95:321–9.
Spix JB, Martius CF. Reise in Brasilien. Munchen. Traduction in portuguese. 1823. Rio de Janeiro: Ed. Itatiaia, EDUSP; 1981. p. 97–240.
Kidder DP, Fletcher JC. Brazil and the brazilians. Philadelphia: Ed. Childs & Peterson; 1857. p. 416–8.
Ferreira LF, Reinhard KJ, Araújo A. Fundamentos da paleoparasitologia. Rio de Janeiro: Edit. Fiocruz; 2011. p. 437–53.
Koberle F. The causation and importance of nervous lesions in American trypanosomiasis. Bull WHO. 1970;42:739–43.
Zingales B, Miles MA, Campbell DA, Tibayrenc M, Macedo AM, Teixeira MM, Schijman AG, Llewellyn MS, Lages-Silva E, Machado CR, Andrade SG, Sturm NR. The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infect Genet Evol. 2012;12:240–53.
Luquetti AO, Miles MA, Rassi A, de Rezende JM, De Souza AA, Povoa MM, Rodrigues I. Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas’ disease in central Brazil. Trans R Soc Trop Med Hyg. 1986;80:462–70.
Atias A, Neghme A, Aguirre Mackay L, Jarpas S. Megaesophagus, megacolon and Chagas disease in Chile. Gastroenterology. 1963;44:433.
de Rezende JM, Luquetti AO. Chagasic Megavisceras. In: Pan American Health Organization, editor. Chagas’ disease and the nervous system. Scientific publication no. 547. Washington, DC: Pan American Health Organization; 1994. p. 149–71.
Luquetti AO. Megaesôfago e anticorpos anti-Trypanosoma cruzi. Rev Goiana Med. 1987;33:1–16.
Rassi A, Rezende JM, Moreira H, Ximenes CA, Luquetti AO, Lousa L, Ferrioli Filho F. Associação de cardiopatia, megaesôfago e megacolo na fase crônica da doença de Chagas. Rev Soc Bras Med Trop. 1986;19. (Suppl. 2:29.
Oliveira EC, Leite MS, Miranda JA, Andrade AL, Garcia SB, Luquetti AO, Moreira H. Chronic Trypanosoma cruzi infection associated with low incidence of 1,2-dimethylhydrazine-induced colon cancer in rats. Carcinogenesis. 2001;22:737–40.
Garcia SB, Aranha AL, Garcia FR, Basile FV, Pinto AP, de Oliveira EC, Zucoloto S. A retrospective study of histopathological findings in 894 cases of megacolon: what is the relationship between megacolon and colonic cancer? Rev Inst Med Trop Sao Paulo. 2003;45:91–3.
World Health Organization. Control of Chagas disease WHO technical report series N° 905. Second report of the WHO Expert Committee. Geneva: World Health Organization; 2002.
Rassi A, Rezende JM, Luquetti AO, Rassi A Jr. Clinical phases and forms of Chagas disease. In: Telleria J, Tibayrenc M, editors. American Trypanosomiasis. Chagas disease. One hundred years of research. 2nd ed. Amsterdam: Elsevier; 2017.
Chagas C. Processos patogênicos da tripanosomíase americana. Mem Inst Oswaldo Cruz. 1916;8:5–37.
Corbett CE, UJr R, Prianti MG, Habr-Gama A, Okumura M, Gama-Rodrigues J. Cell-mediated immune response in megacolon from patients with chronic Chagas’ disease. Dis Colon Rectum. 2001;44:993–8.
da Silveira AB, Adad SJ, Correa-Oliveira R, Furness JB, D’Avila Reis D. Morphometric study of eosinophils, mast cells, macrophages and fibrosis in the colon of chronic chagasic patients with and without megacolon. Parasitology. 2007;134:789–96.
Campos JV, Tafuri WL. Chagas enteropathy. Gut. 1973;14:910–9.
Tafuri WL, Maria TA, Lopes ER. Myenteric plexus lesions in the esophagus, jejunum and colon of chronic chagasic patients. Electron microscopy study. Rev Inst Med Trop Sao Paulo. 1971;13:76–91.
Almeida HO, Teixeira VP, Gobbi H, Rocha A, Brandao MC. Inflammation associated with cardiac muscle cells parasitized by Trypanosoma cruzi, in chronic Chagas’ disease patients. Arq Bras Cardiol. 1984;42:183–6.
Furness JB, Young HM, Pompolo S, Bornstein JC, Kunze WA, McConalogue K. Plurichemical transmission and chemical coding of neurons in the digestive tract. Gastroenterology. 1995;108:554–63.
Furness JB, Costa M. Types of nerves in the enteric nervous system. Neuroscience. 1980;5:1–20.
Furness JB. The enteric nervous system: normal functions and enteric neuropathies. Neurogastroenterol Motil. 2008;20(Suppl 1):32–8.
Gabella G. Ultrastructure of the nerve plexuses of the mammalian intestine: the enteric glial cells. Neuroscience. 1981;6:425–36.
da Silveira AB, D’Avila Reis D, de Oliveira EC, Neto SG, Luquetti AO, Poole D, Correa-Oliveira R, Furness JB. Neurochemical coding of the enteric nervous system in chagasic patients with megacolon. Dig Dis Sci. 2007;52:2877–83.
Furness JB, Jones C, Nurgali K, Clerc N. Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog Neurobiol. 2004;72:143–64.
Cruvinel W de M, DJr M, Araujo JA, Catelan TT, de Souza AW, da Silva NP, Andrade LE. Immune system – part I. Fundamentals of innate immunity with emphasis on molecular and cellular mechanisms of inflammatory response. Rev Bras Reumatol. 2010;50:434–61.
Kodali S, Ding W, Huang J, Seiffert K, Wagner JA, Granstein RD. Vasoactive intestinal peptide modulates Langerhans cell immune function. J Immunol. 2004;173:6082–8.
Schmidt K, Klatt P, Mayer B. Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells. Biochem J. 1994;301:313–6.
Rezende JM. Rev Med Chil. 1979). [Chagas disease of the digestive tract (author’s transl);107:71–2.
da Silveira AB, Arantes RM, Vago AR, Lemos EM, Adad SJ, Correa-Oliveira R, D’Avila Reis D. Comparative study of the presence of Trypanosoma cruzi kDNA, inflammation and denervation in chagasic patients with and without megaesophagus. Parasitology. 2005;131:627–34.
da Silveira AB, Lemos EM, Adad SJ, Correa-Oliveira R, Furness JB, D’Avila Reis D. Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells. Hum Pathol. 2007;38:1256–64.
Sato H, Leo N, Katakai Y, Takano J, Akari H, Nakamura S, Une Y. Prevalence and molecular phylogenetic characterization of Trypanosoma (Megatrypanum) minasense in the peripheral blood of small neotropical primates after a quarantine period. J Parasitol. 2008;94:1128–38.
Souza DHS, Vaz MGM, Fonseca CR, Luquetti A, Rezende Filho J, Oliveira EC. Current epidemiological profile of chagasic megaesophagus in Central Brazil. Rev Soc Bras Med Trop. 2013;46:316–21.
Rezende JM, Lauar KL, Oliveira AR. Aspectos clinicos e radiologicos da aperistalsis do esôfago. Rev Bras Gastroenterol. 1960;12:247–62.
Aquino JL, Said MM, Pereira DA, Leandro-Merhi VA, Nascimento PC, Reis VV. Early and late assessment of esophagocardioplasty in the surgical treatment of advanced recurrent megaesophagus. Arq Gastroenterol. 2016;53:235–9.
Asti E, Sironi A, Lovece A, Bonavina G, Fanelli M, Bonitta G, Bonavina L. Health-related quality of life after laparoscopic Heller myotomy and Dor fundoplication for achalasia. Surgery. 2017;161:977–83.
Allaix ME, Patti MG. Toward a tailored treatment of Achalasia: an evidence-based approach. J Laparoendosc Adv Surg Tech. 2016;26:256–63.
Ponciano H, Cecconello I, Alves L, Ferreira BD, Gama-Rodrigues J. Cardiaplasty and Roux-en-Y partial gastrectomy (Serra-Dória procedure) for reoperation of achalasia. Arq Gastroenterol. 2004;41:155–61.
Herbella FA, Aquino JL, Stefani-Nakano S, Artifon EL, Sakai P, Crema E, Andreollo NA, Lopes LR, de Castro Pochini C, Corsi PR, Gagliardi D, Del Grande JC. Treatment of achalasia: lessons learned with Chagas’ disease. Dis Esophagus. 2008;21:461–7.
Pochini Cde C, Gagliardi D, Saad Júnior R, de Almeida RF, Corsi PR. Esophagectomy with gastroplasty in advanced megaesophagus: late results of omeprazole use. Rev Col Bras Cir. 2015;42:299–304.
Zilberstein B, Franciss MY, Genovesi A, Volpe P, Domene CE, Barchi LC. Pioneer robotic Serra-Doria Operation for recurrent Achalasia After Heller’s cardiomyotomy: a “new quondam” procedure. J Laparoendosc Adv Surg Tech A. 2017;27:524–8.
Rebecchi F, Allaix ME, Morino M. Robotic technological aids in esophageal surgery. J Vis Surg. 2017;8:3–7.
Brant C, Moraes-Filho JP, Siqueira E, Nasi A, Libera E, Morais M, Rohr M, Macedo EP, Alonso G, Ferrari AP. Intrasphincteric botulinum toxin injection in the treatment of chagasic achalasia. Dis Esophagus. 2003;16:33–8.
Uppal DS, Wang AY. Update on the endoscopic treatments for achalasia. World J Gastroenterol. 2016;22:8670–83.
Gladman MA, Dvorkin LS, Scott MS, Lunniss PJ, Williams NS. A novel technique to identify patients with megarectum. Dis Colon Rectum. 2007;50:621–9.
Anand AC, Sashindran VK, Mohan L. Gastrointestinal problems at high altitude. Trop Gastroenterol. 2006;27:147–53.
Oliveira EC, Menezes JG, Cardoso VK, Luquetti AO, Neto SG, Garcia SB. The Relationship between megacolon and constipation in Chagas’ disease. Neurogastroenterol Motil. 2009;21(Suppl 1):5.
Bafutto M, Luquetti AO, Gabriel Neto S, Penhavel FAS, Oliveira EC. Constipation is related to small bowel disturbance rather than colonic enlargement in acquired chagasic megacolon. Gastroenterol Res. 2017;10:213–7.
Oliveira EC, Gabriel Neto S, Bafutto M, Luquetti AO. False-negative rectoanal inhibitory reflex in acquired megacolon. Annual scientific meeting. American Society of Colon and Rectum Surgeons.
Cavenaghi S, Felicio OCS, Ronchi LS, Cunrath GS, Melo MMC, Netinho JG. Prevalence of rectoanal inhibitory reflex in chagasic megacólon. Arq Gastroenterol. 2008;45:128–31.
Castro C, Hernandez EB, Rezende JM, Prata A. Radiological study on megacolon cases in an endemic area for Chagas disease. Rev Soc Bras Med Trop. 2010;43:562–6.
Shafik A, Mostafa RM, Shafik I, EI-Sibai O, Shafik AA. Functional activity of the rectum: a conduit organ or a storage organ or both. World J Gastroenterol. 2006;12:4549–52.
Duhamel B. New operation for congenital megacolon: retrorectal and transanal lowering of the colon, and its possible application to the treatment of various other malformations. Presse Med. 1956;64:2249–50.
Oliveira AB. Tratamento cirúrgico do megacólon pela operação de Duhamel. Rev Paul Med. 1963;63:283–304.
Haddad J, Raia A, Correa Neto A. Abaixamento retro-retal do colon com colostomia perineal no tratamento do megacólon adquirido. Rev Assoc Med Bras. 1965;11:83–8.
Reis Neto JA. Resultados tardios da operação de Duhamel no tratamento do megacólon adquirido. Rev Assoc Med Bras. 1970;18:57–62.
Salerno G, Sinnatamby C, Branagan G, Daniels IR, Heald RJ, Moran BJ. Defining the rectum: surgically, radiologically and anatomically. Color Dis. 2006;8. (Suppl. 3:5–9.
Gabriel Neto S, Oliveira EC, Ramos GC, Gabriel AG, Habr-Gama A, Zilberstein B, Luquetti AO. Treatment of megacolon: low anterior resection vs. Duhamel procedure evaluated by colonic transit time. Dis Colon Rectum. 2009;50:798.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
de Oliveira, Ê.C., da Silveira, A.B.M., Luquetti, A.O. (2019). Gastrointestinal Chagas Disease. In: Altcheh, J., Freilij, H. (eds) Chagas Disease. Birkhäuser Advances in Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-00054-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-00054-7_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-00053-0
Online ISBN: 978-3-030-00054-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)